RSNA: Penrad acquires Clarios Compass breast MRI software

TriMed Staff | | Health Imaging | Breast MRI
PenRad Technologies (Booth 4600) has purchased Clario Medical Imaging's Compass breast MRI visualization and analysis software, which PenRad will launch at the annual meeting of the Radiological Society of North America (RSNA), Nov. 28 to Dec. 3, in Chicago.

Compass is a breast MRI visualization and analysis software system that provides image surface and parametric maps, maximum intensity projection, registered subtraction, 3D display and visual enhancement of time/intensity changes of breast lesions, according to PenRad.

Clario originally developed the software, which has received FDA clearance. Compass can be purchased as a stand-alone software program or integrated into PenRad's PenView Women's Imaging Workstation.

TriMed Staff

Related Content

AI model spots up to 30% of breast cancers missed on MRI
Breast cancer only visible via MRI is often less aggressive
The pros and cons of current breast screening modalities and the role of AI
AI tool's supplemental MRI recs help detect 4 times more breast cancers than density measures
Applying Node-RADS to breast MRI exams improves staging
New study results 'strongly' back supplemental MRI for women with dense breasts

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.